NIH funding uncertainty clouds US research, dampens biotech investor sentiment

The latest episode of STAT’s “The Readout LOUD” podcast examined how the National Institutes of Health is allocating its budget and the growing uncertainty surrounding future funding.

Hosts Elaine Chen, Allison DeAngelis and Adam Feuerstein highlighted that the lack of clarity is hindering U.S. researchers, with many projects facing delays or scaling back. They noted that investors in biotech are reacting with caution, reflecting a gloomy outlook.

The discussion also featured STAT reporter Anil Oza and Heather Pierce, senior director of science policy, who provided additional context on the policy environment. Listeners were invited to follow the conversation for deeper insight into how funding trends may shape the sector.